Atlas Trials

Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD

Clinical trial NCT02937974 · UNKNOWN

Trial details

NCT number
NCT02937974
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2016-10-01
Primary completion
2018-12-01
Enrollment
254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.